Bovine Milk Oligosaccharide for Healthy Subjects (BMO Trial)

N/A

Waitlist Available

Led By Carolyn Slupsky, PhD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up minus day 7 and days 0-10

Awards & highlights

BMO Trial Summary

This trial is testing if it's safe and effective to consume bovine milk oligosaccharides to improve gut health.

BMO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ minus day 7 and days 0-10

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~minus day 7 and days 0-10

This trial's timeline: 3 weeks for screening, Varies for treatment, and minus day 7 and days 0-10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gut microbiota

Secondary outcome measures

Dietary Macronutrient Intake

Fecal BMO

Fecal Metatranscriptome

+5 more

BMO Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment 3: High-Dose BMOExperimental Treatment1 Intervention

Treatment 3: Bovine Milk Oligosaccharide (BMO) powder (Hilmar Ingredients, Hilmar, California 95324) Dosage: 35% of individual daily fiber intake, split into two daily servings Frequency: Two servings per day (for total of 25% dosage per day) Duration: 11 days, followed by a 2-week wash-out period Fiber intake was 35% of each individual's daily fiber intake based on calculated energy expenditure (14 grams of fiber for every 1000 kcal consumed) for eleven consecutive days.

Group II: Treatment 2: Low-Dose BMOExperimental Treatment1 Intervention

Treatment 2: Bovine Milk Oligosaccharide (BMO) powder (Hilmar Ingredients, Hilmar, California 95324) Dosage: 25% of individual daily fiber intake, split into two daily servings Frequency: Two servings per day (for total of 25% dosage per day) Duration: 11 days, followed by a 2-week wash-out period Fiber intake was 25% of each individual's daily fiber intake based on calculated energy expenditure (14 grams of fiber for every 1000 kcal consumed) for eleven consecutive days.

Group III: Placebo Control, Glucose polymerPlacebo Group1 Intervention

Treatment 1: Polycose Glucose Polymer Module powder (Abbott Nutrition, Abbott Park, Illinois 60064), fed as 25% of each individual's daily fiber intake based on calculated energy expenditure (14 grams of fiber for every 1000 kcal consumed) for eleven consecutive days.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bovine Milk Oligosaccharide

2012

N/A

~20

Do I qualify?Apply below to find out